A Trial Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® in Children With Growth Hormone Deficiency
A Trial Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® in Children With Growth Hormone Deficiency
The study compares 2 medicines for children who do not have enough hormone to grow: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Researchers will test to see how well somapacitan works. The study will also test if somapacitan is safe. Participants will either get somapacitan or Norditropin® - which treatment participants get, is decided by chance. Both participants and the study doctor will know which treatment participants get. The study will last for 4 years. Participants will attend 19 clinic visits and have 1 phone call with the study doctor.
Inclusion Criteria:
Exclusion Criteria:
Copenhagen Ø, 2100, Denmark
Marseille Cédex 05, 13385, France
New Dehli, New Delhi 110029, India
Fukuoka-shi, Fukuoka, 813-0017, Japan
Kobe-shi, Hyogo, 650-0047, Japan
Mito, Ibaraki, 311-4145, Japan
Nara-shi, Nara, 630-8581, Japan
Niigata-shi, Niigata, 951 8520, Japan
Okayama-shi, Okayama, 701-1192, Japan
Rzeszów, Podkarpackie Voivodeship 35-301, Poland
Esplugues Llobregat(Barcelona), 08950, Spain
Kyiv, 04114, Ukraine
Vinnytsia, 21010, Ukraine